We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current DAWN market cap is 784.48M. The company's latest EPS is USD -0.9422 and P/E is -8.20.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 8.19M | 93.76M | 29.21M |
| Operating Income | -59.52M | -66.77M | -114.81M | 29.64M | -65.33M |
| Net Income | -54.51M | -62.41M | -4.41M | 37.04M | -65.71M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 131.16M |
| Operating Income | -13.78M | -72.74M | -146.91M | -206.06M | -217.27M |
| Net Income | -40.51M | -170.64M | -142.18M | -188.92M | -95.5M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 376.05M | 326.65M | 400.44M | 600.81M | 582.79M |
| Total Liabilities | 29.51M | 29.84M | 93.71M | 45.34M | 80.04M |
| Total Equity | 346.54M | 296.81M | 306.73M | 555.46M | 502.75M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 45.66M | 289.82M | 349.06M | 376.05M | 582.79M |
| Total Liabilities | 2.2M | 8.67M | 17.02M | 29.51M | 80.04M |
| Total Equity | -54.21M | 281.15M | 332.04M | 346.54M | 502.75M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -146.85M | -49.73M | -98.86M | -48.11M | -78.11M |
| Investing | 128.38M | 89.29M | 106.35M | 38.65M | -230.99M |
| Financing | 164M | 48k | 1.35M | 201.44M | 203.29M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.49M | -48.54M | -109.87M | -146.85M | -78.11M |
| Investing | -92k | -8M | -255.07M | 128.38M | -230.99M |
| Financing | 29.98M | 297.12M | 165.9M | 164M | 203.29M |
| Market Cap | 784.48M |
| Price to Earnings Ratio | -8.20 |
| Price to Sales Ratio | 5.97 |
| Price to Cash Ratio | 6.27 |
| Price to Book Ratio | 1.56 |
| Dividend Yield | - |
| Shares Outstanding | 101.35M |
| Average Volume (1 week) | 1.21M |
| Average Volume (1 Month) | 1.15M |
| 52 Week Change | -47.70% |
| 52 Week High | 18.0699 |
| 52 Week Low | 6.41 |
| Spread (Intraday) | 0.23 (2.93%) |
| Company Name | Day One Biopharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.dayonebio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
